BROOKFIELD ASSET MGMT-A (BAM)

CA1130041058 - Common Stock

54.42  +0.2 (+0.37%)

After market: 54 -0.42 (-0.77%)

Fundamental Rating

4

BAM gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 220 industry peers in the Capital Markets industry. BAM has only an average score on both its financial health and profitability. BAM is valied quite expensively at the moment, while it does show a decent growth rate.



4

1. Profitability

1.1 Basic Checks

In the past year BAM was profitable.
In the past year BAM had a positive cash flow from operations.
In the past 5 years BAM has always been profitable.
BAM had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

BAM's Return On Assets of 10.41% is amongst the best of the industry. BAM outperforms 86.64% of its industry peers.
BAM has a Return On Equity of 13.99%. This is in the better half of the industry: BAM outperforms 74.19% of its industry peers.
BAM has a worse Return On Invested Capital (1.55%) than 72.81% of its industry peers.
BAM had an Average Return On Invested Capital over the past 3 years of 3.33%. This is below the industry average of 7.00%.
Industry RankSector Rank
ROA 10.41%
ROE 13.99%
ROIC 1.55%
ROA(3y)7.32%
ROA(5y)4.86%
ROE(3y)13.82%
ROE(5y)10.26%
ROIC(3y)3.33%
ROIC(5y)N/A

1.3 Margins

With an excellent Profit Margin value of 86.21%, BAM belongs to the best of the industry, outperforming 95.39% of the companies in the same industry.
In the last couple of years the Profit Margin of BAM has grown nicely.
BAM has a worse Operating Margin (13.03%) than 68.20% of its industry peers.
BAM's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 13.03%
PM (TTM) 86.21%
GM N/A
OM growth 3Y-40.15%
OM growth 5Y-3.5%
PM growth 3Y85.4%
PM growth 5Y79.53%
GM growth 3YN/A
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

Compared to 1 year ago, BAM has less shares outstanding
BAM has less shares outstanding than it did 5 years ago.
The debt/assets ratio for BAM is higher compared to a year ago.

2.2 Solvency

BAM has an Altman-Z score of 13.15. This indicates that BAM is financially healthy and has little risk of bankruptcy at the moment.
BAM has a better Altman-Z score (13.15) than 98.16% of its industry peers.
BAM has a debt to FCF ratio of 0.39. This is a very positive value and a sign of high solvency as it would only need 0.39 years to pay back of all of its debts.
The Debt to FCF ratio of BAM (0.39) is better than 90.32% of its industry peers.
BAM has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of BAM (0.07) is better than 82.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 0.39
Altman-Z 13.15
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.87 indicates that BAM may have some problems paying its short term obligations.
BAM's Current ratio of 0.87 is in line compared to the rest of the industry. BAM outperforms 40.09% of its industry peers.
A Quick Ratio of 0.87 indicates that BAM may have some problems paying its short term obligations.
BAM has a Quick ratio (0.87) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.87

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.68% over the past year.
Measured over the past years, BAM shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.79% on average per year.
Looking at the last year, BAM shows a very negative growth in Revenue. The Revenue has decreased by -61.04% in the last year.
BAM shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -63.20% yearly.
EPS 1Y (TTM)3.68%
EPS 3Y4.81%
EPS 5Y-9.79%
EPS Q2Q%8.57%
Revenue 1Y (TTM)-61.04%
Revenue growth 3Y-43.77%
Revenue growth 5Y-63.2%
Sales Q2Q%35.5%

3.2 Future

BAM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.78% yearly.
The Revenue is expected to grow by 12.93% on average over the next years. This is quite good.
EPS Next Y6.04%
EPS Next 2Y12.54%
EPS Next 3Y13.78%
EPS Next 5YN/A
Revenue Next Year7.47%
Revenue Next 2Y12.37%
Revenue Next 3Y12.93%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

BAM is valuated quite expensively with a Price/Earnings ratio of 38.60.
BAM's Price/Earnings ratio is a bit more expensive when compared to the industry. BAM is more expensive than 77.88% of the companies in the same industry.
BAM's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.73.
The Price/Forward Earnings ratio is 31.36, which means the current valuation is very expensive for BAM.
Based on the Price/Forward Earnings ratio, BAM is valued a bit more expensive than the industry average as 75.12% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 22.83. BAM is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 38.6
Fwd PE 31.36

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BAM is on the same level as its industry peers.
BAM's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 43.44
EV/EBITDA 293.84

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BAM does not grow enough to justify the current Price/Earnings ratio.
BAM's earnings are expected to grow with 13.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)6.39
PEG (5Y)N/A
EPS Next 2Y12.54%
EPS Next 3Y13.78%

3

5. Dividend

5.1 Amount

BAM has a Yearly Dividend Yield of 2.33%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 9.45, BAM is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.34, BAM has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.33%

5.2 History

BAM has paid a dividend for at least 10 years, which is a reliable track record.
BAM has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)N/A
Div Incr Years6
Div Non Decr Years6

5.3 Sustainability

BAM pays out 132.44% of its income as dividend. This is not a sustainable payout ratio.
DP132.44%
EPS Next 2Y12.54%
EPS Next 3Y13.78%

BROOKFIELD ASSET MGMT-A

NYSE:BAM (12/20/2024, 8:04:00 PM)

After market: 54 -0.42 (-0.77%)

54.42

+0.2 (+0.37%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-04 2024-11-04/bmo
Earnings (Next)02-05 2025-02-05/amc
Inst Owners70.24%
Inst Owner Change-90.76%
Ins Owners7.17%
Ins Owner ChangeN/A
Market Cap24.11B
Analysts66
Price Target55.5 (1.98%)
Short Float %2.14%
Short Ratio7.83
Dividend
Industry RankSector Rank
Dividend Yield 2.33%
Dividend Growth(5Y)N/A
DP132.44%
Div Incr Years6
Div Non Decr Years6
Ex-Date11-29 2024-11-29 (0.38)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.59%
Min EPS beat(2)-2.55%
Max EPS beat(2)5.74%
EPS beat(4)2
Avg EPS beat(4)1.27%
Min EPS beat(4)-3.62%
Max EPS beat(4)5.74%
EPS beat(8)5
Avg EPS beat(8)2.44%
EPS beat(12)8
Avg EPS beat(12)22.85%
EPS beat(16)10
Avg EPS beat(16)68.65%
Revenue beat(2)0
Avg Revenue beat(2)-1.06%
Min Revenue beat(2)-1.54%
Max Revenue beat(2)-0.58%
Revenue beat(4)0
Avg Revenue beat(4)-0.95%
Min Revenue beat(4)-1.54%
Max Revenue beat(4)-0.36%
Revenue beat(8)1
Avg Revenue beat(8)-5.24%
Revenue beat(12)2
Avg Revenue beat(12)-3.4%
Revenue beat(16)4
Avg Revenue beat(16)122.29%
PT rev (1m)18.85%
PT rev (3m)27.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.93%
EPS NY rev (1m)0.51%
EPS NY rev (3m)2.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.42%
Revenue NY rev (1m)1.96%
Revenue NY rev (3m)2.04%
Valuation
Industry RankSector Rank
PE 38.6
Fwd PE 31.36
P/S 46.19
P/FCF 43.44
P/OCF 40.59
P/B 7.49
P/tB 7.49
EV/EBITDA 293.84
EPS(TTM)1.41
EY2.59%
EPS(NY)1.74
Fwd EY3.19%
FCF(TTM)1.25
FCFY2.3%
OCF(TTM)1.34
OCFY2.46%
SpS1.18
BVpS7.26
TBVpS7.26
PEG (NY)6.39
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.41%
ROE 13.99%
ROCE 2.09%
ROIC 1.55%
ROICexc 1.56%
ROICexgc 1.59%
OM 13.03%
PM (TTM) 86.21%
GM N/A
FCFM 106.32%
ROA(3y)7.32%
ROA(5y)4.86%
ROE(3y)13.82%
ROE(5y)10.26%
ROIC(3y)3.33%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)4.39%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-40.15%
OM growth 5Y-3.5%
PM growth 3Y85.4%
PM growth 5Y79.53%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 0.39
Debt/EBITDA 2.66
Cap/Depr 278.57%
Cap/Sales 7.47%
Interest Coverage 4.25
Cash Conversion 724.39%
Profit Quality 123.33%
Current Ratio 0.87
Quick Ratio 0.87
Altman-Z 13.15
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)237.01%
Cap/Depr(5y)202.68%
Cap/Sales(3y)15.66%
Cap/Sales(5y)9.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.68%
EPS 3Y4.81%
EPS 5Y-9.79%
EPS Q2Q%8.57%
EPS Next Y6.04%
EPS Next 2Y12.54%
EPS Next 3Y13.78%
EPS Next 5YN/A
Revenue 1Y (TTM)-61.04%
Revenue growth 3Y-43.77%
Revenue growth 5Y-63.2%
Sales Q2Q%35.5%
Revenue Next Year7.47%
Revenue Next 2Y12.37%
Revenue Next 3Y12.93%
Revenue Next 5YN/A
EBIT growth 1Y-93.06%
EBIT growth 3Y-66.34%
EBIT growth 5Y-64.49%
EBIT Next Year7.39%
EBIT Next 3Y16.64%
EBIT Next 5YN/A
FCF growth 1Y-88.15%
FCF growth 3Y-35.81%
FCF growth 5Y-31.93%
OCF growth 1Y49.62%
OCF growth 3Y-34.24%
OCF growth 5Y-37.1%